A plain-language guide · U.S. care

Semaglutide
clinic online

Let's make sense of the care.

Curious about care from home? Start with the medicine, the visit, and the people responsible for each.

The medicine

What is semaglutide?

Semaglutide (Ozempic, Wegovy) copies a gut hormone, a signal the body releases after eating.

It helps the brain register fullness and helps the body manage blood sugar.
The ingredient name alone does not tell you which health problems a product is approved to treat.

As of September 2026, Wegovy has an approved use for weight management.

As of September 2026, Ozempic’s approved uses concern adults with type 2 diabetes, a blood sugar condition.
Ask which product fits the reason for your care.

The visit

Telehealth means medical care from a distance, such as a video visit, phone call, or online messages with a doctor.

During your visit, the doctor needs a licence or other state permission for the state where you are (as of September 2026).

States set their own rules for doctors writing prescriptions online; advice from a national group does not replace state rules.
Ask about the state where you will be sitting, including when travelling.

A visit is a chance to talk through your history and ask what the plan would involve.

Have your medicine list and health questions nearby.
Ask whether you will fill in a form, talk to a doctor, or need an examination. Who reviews your health and decides about treatment?
Ask how to reach the doctor or someone on the care team after the visit.

The Federation of State Medical Boards advised in May 2026 that proper care requires more than choosing a drug from a menu.

This group gives advice to state medical boards, the groups that license doctors. Each state decides which rules its doctors must follow.

A different product question

When a pharmacy or doctor makes medicine for an individual patient rather than using a finished drug-company product, that is compounding.

The U.S. agency responsible for reviewing medicines is called the Food and Drug Administration (FDA).

As of September 2026, compounded medicines do not have FDA approval. Before these products go on sale, the agency does not review their quality, safety, or how well they work.
As of September 2026, the FDA’s nationwide shortage list does not include semaglutide injections.
Under September 2026 rules, a pharmacy cannot routinely make close copies of a drug-company medicine.
A change for your own health needs may be an exception. The person writing your prescription must record why it makes an important difference compared with the drug-company medicine, for you by name.
A cheaper price, on its own, is not a reason for this exception.
Adding a vitamin to the same injection does not, by itself, put it outside the copying rules.
Ask what change is being made for you and why an approved medicine cannot meet that need.
Which pharmacy will make it? Ask for that pharmacy’s name.

Follow the evidence

The medicine and its label

The government-hosted Wegovy label describes its uses, how it acts, and the checks discussed during care.

The standard for an online visit

Read this advice on how a doctor reviews your health and leaves room for your questions.

Permission to practise across state lines

Federal guidance explains why the patient’s location matters when care happens online.

The limits on compounded copies

Read the FDA’s explanation of the supply of semaglutide injections and the rules for pharmacy-made copies.

What the FDA checks before a medicine is sold

Read how a pharmacy-made medicine differs from a finished drug-company product.

The diabetes product’s label

The government-hosted product information gives the uses for the diabetes injection.